BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34470951)

  • 1. N-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride.
    Yokoo H; Yamamoto E; Masada S; Uchiyama N; Tsuji G; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y
    Chem Pharm Bull (Tokyo); 2021; 69(9):872-876. PubMed ID: 34470951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature-Dependent Formation of N-Nitrosodimethylamine during the Storage of Ranitidine Reagent Powders and Tablets.
    Abe Y; Yamamoto E; Yoshida H; Usui A; Tomita N; Kanno H; Masada S; Yokoo H; Tsuji G; Uchiyama N; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y; Okuda H
    Chem Pharm Bull (Tokyo); 2020 Oct; 68(10):1008-1012. PubMed ID: 32779580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of N-nitrosodimethylamine formation from the ozonation of ranitidine.
    Lv J; Wang L; Li Y
    J Environ Sci (China); 2017 Aug; 58():116-126. PubMed ID: 28774600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranitidine: A Proposed Mechanistic Rationale for NDMA Formation and a Potential Control Strategy.
    Harmon P
    J Pharm Sci; 2023 May; 112(5):1220-1224. PubMed ID: 36384193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation mechanism of NDMA from ranitidine, trimethylamine, and other tertiary amines during chloramination: a computational study.
    Liu YD; Selbes M; Zeng C; Zhong R; Karanfil T
    Environ Sci Technol; 2014; 48(15):8653-63. PubMed ID: 24968236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of N-nitrosodimethylamine formation from ranitidine by ozonation preceding chloramination: influencing factors and mechanisms.
    Zou R; Liao X; Zhao L; Yuan B
    Environ Sci Pollut Res Int; 2018 May; 25(14):13489-13498. PubMed ID: 29492817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bioanalytical Method for Quantification of N-nitrosodimethylamine (NDMA) in Human Plasma and Urine with Different Meals and following Administration of Ranitidine.
    De Palma R; Patel V; Florian J; Keire D; Selaya D; Strauss DG; Rouse R; Matta MK
    J Pharm Sci; 2023 May; 112(5):1315-1323. PubMed ID: 36736776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of high-performance liquid chromatography-Orbitrap mass spectrometric method for quantification of NDMA in ranitidine drug products and evaluation of antioxidants as inhibitors of classical nitrosation reaction.
    Aishwarya D; Nikhil P; Natesan S; Velayutham R; Peraman R
    Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9747. PubMed ID: 38600640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NDMA formation kinetics from three pharmaceuticals in four water matrices.
    Shen R; Andrews SA
    Water Res; 2011 Nov; 45(17):5687-94. PubMed ID: 21903238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDMA formation by chloramination of ranitidine: kinetics and mechanism.
    Roux JL; Gallard H; Croué JP; Papot S; Deborde M
    Environ Sci Technol; 2012 Oct; 46(20):11095-103. PubMed ID: 22967139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings.
    Aldawsari FS; Alshehry YM; Alghamdi TS
    J Food Drug Anal; 2021 Mar; 29(1):39-45. PubMed ID: 35696227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloramination of nitrogenous contaminants (pharmaceuticals and pesticides): NDMA and halogenated DBPs formation.
    Le Roux J; Gallard H; Croué JP
    Water Res; 2011 May; 45(10):3164-74. PubMed ID: 21496861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HS-SPME-GC-MS as an alternative method for NDMA analysis in ranitidine products.
    Alshehri YM; Alghamdi TS; Aldawsari FS
    J Pharm Biomed Anal; 2020 Nov; 191():113582. PubMed ID: 32889348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of N-nitrosodimethylamine from drug substances using solid-phase extraction-liquid chromatography-tandem mass spectrometry.
    Yamamoto E; Kan-No H; Tomita N; Ando D; Miyazaki T; Izutsu KI
    J Pharm Biomed Anal; 2022 Feb; 210():114561. PubMed ID: 34974238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine.
    Zeng T; Mitch WA
    Carcinogenesis; 2016 Jun; 37(6):625-634. PubMed ID: 26992900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Analysis of N-Nitrosodimethylamine (NDMA) Formation From Ranitidine Under Simulated Gastrointestinal Conditions.
    Gao Z; Karfunkle M; Ye W; Marzan TA; Yang J; Lex T; Sommers C; Rodriguez JD; Han X; Florian J; Strauss DG; Keire DA
    JAMA Netw Open; 2021 Jun; 4(6):e2118253. PubMed ID: 34181009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of ranitidine and changes in N-nitrosodimethylamine formation potential by advanced oxidation processes: Role of oxidant speciation and water matrix.
    Seid MG; Lee C; Cho K; Hong SW
    Water Res; 2021 Sep; 203():117495. PubMed ID: 34388496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of ranitidine during water chlorination and ozonation: Moiety-specific reaction kinetics and elimination efficiency of NDMA formation potential.
    Jeon D; Kim J; Shin J; Hidayat ZR; Na S; Lee Y
    J Hazard Mater; 2016 Nov; 318():802-809. PubMed ID: 27381234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of amine-based pharmaceuticals with unactivated peroxymonosulfate: Kinetics, mechanisms, and elimination efficiency of NDMA formation.
    Zhou Y; Fu J; Zeng Z; Gao Y; Zhang Z; Han B; Ma J; Jiang J
    J Hazard Mater; 2024 Feb; 463():132961. PubMed ID: 37951171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of
    Liu J; Zhao Z; Yang X; Jin Y; Liu X; Wang C; Zhang Z
    Iran J Pharm Res; 2021; 20(4):255-264. PubMed ID: 35194444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.